Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-21-068510

President and CEO bought 42,518 shares at an average $12.44 ($529,102)

From the SEC's structured data for this filing

Trades in this filing

Session R.A. II · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-23 Purchase : show line 1 in the form +16,510 $12.12 $200,101 9,164,912 D
2021-11-23 Purchase : show line 2 in the form +26,008 $12.65 $329,001 9,190,920 D
Open-market purchases · 42,518 sh · avg $12.44 · $529,102
Loading xslF345X03/doc4.xml…